INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUS
对烟曲霉的免疫反应的启动
基本信息
- 批准号:10449393
- 负责人:
- 金额:$ 67.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-06-06 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAmplifiersAntifungal AgentsAspergillosisAspergillusAspergillus fumigatusBindingBone Marrow TransplantationCOVID-19 patientCXC ChemokinesCXCL10 geneCell DeathCell Death ProcessCellsDataDefectDendritic CellsDiseaseElementsEndothelial CellsEndotheliumEpithelialEpithelial CellsEtiologyEukaryotaFrightFundingGoalsGranulocyte-Macrophage Colony-Stimulating FactorHematologic NeoplasmsHost DefenseHumanHyphaeImmuneImmune responseImmune systemImmunityImmunocompetentImmunocompromised HostIndividualInfectionInhalationInnate Immune SystemIntensive Care UnitsInterferonsInterleukin-1 ReceptorsKnowledgeLeadLigandsLungLung TransplantationMediatingMediator of activation proteinMetabolismModelingMoldsMolecularMolecular TargetMucous MembraneMycosesMyelogenousMyeloid CellsNADPH OxidaseNatural ImmunityOutcomeOxidasesParticipantPatientsPentosephosphate PathwayPhagocytesPilot ProjectsPneumoniaProductionPropertyProteomicsReceptor SignalingRegulationReportingReproduction sporesRoleShapesSignal TransductionSourceSystemTestingTherapeuticTissuesTransplant RecipientsWorkbasecellular targetingchemokine receptorcytokineexperimental studyfungushigh risk populationimmune checkpointimmune functionimprovedinflammatory milieuinnate immune functioninnovationinterleukin-23monocytemortalityneutrophilnovelnovel strategiespathogenpathogenic funguspreventreceptorrecruitrespiratorytranscriptomics
项目摘要
PROJECT SUMMARY
Invasive aspergillosis is devastating fungal infection and the most common form of mold pneumonia worldwide,
with an estimated 200,000 cases annually. Aspergillus fumigatus, the most common etiologic agent of invasive
aspergillosis, forms ubiquitous airborne spores that humans inhaled on daily basis. In immune competent
individuals the respiratory innate immune system prevents the formation of tissue-invasive hyphae, a critical
immunologic checkpoint. In patients with hematologic malignancies, in bone marrow and lung transplant
recipients, and recently, in intensive care unit patients with COVID-19, numeric or functional defects in innate
immune function lead to invasive disease. Despite contemporary antifungal drugs, mortality rates remain at 20-
40% in high risk groups, underscoring the need for improved understanding of the molecular and cellular basis
of sterilizing immunity to advance immune-based adjunctive approaches.
In the second funding period, we harnessed a fungal bioreporter that reports the mode of cell death to discover
that neutrophils and monocyte-derived dendritic cells induce a regulated cell death in engulfed fungal cells.
The concept that a higher eukaryote can exploit a regulated cell death machinery in a lower eukaryote is novel
and, in the case of A. fumigatus, depends on host NADPH oxidase activity. NADPH oxidase-dependent fungal
killing is modulated by two novel, essential intercellular crosstalk circuits that involves the early production of
GM-CSF (GM-CSF circuit) and plasmacytoid dendritic cells (pDC circuit).
During the next project period, we propose to gain a deeper understanding of the GM-CSF and pDC circuits. In
Aim 1, we identify the essential cellular source of GM-CSF and, based on preliminary data, focus on pulmonary
endothelial and epithelial cells as regulators of neutrophil-dependent fungal killing. In Aim 2, we define the pDC
circuit and candidate transmitters and test models of direct or indirect activation by fungal cells or the lung
inflammatory milieu. In Aim 3, we define the mechanisms by which the pDC circuit regulates neutrophils, and
test its role in NAPDH oxidase assembly, activation, and neutrophil metabolism via the pentose phosphate
pathway and its cooperativity with the GM-CSF circuit to mediate sterilizing immunity. The proposed studies
are significant and innovative because they integrate innate immune crosstalk between the pulmonary
endothelial, epithelial, and pDC compartments and infected myeloid phagocytes into a comprehensive model
of respiratory immunity against mold pathogens. Understanding the induction, regulation, and participants of
innate immune crosstalk addresses a critical knowledge gap that will inform immune-enhancing strategies in
vulnerable patient groups.
项目概要
侵袭性曲霉病是一种毁灭性的真菌感染,也是全世界最常见的霉菌肺炎,
每年估计有 200,000 起案件。烟曲霉(Aspergillus fumigatus),最常见的侵袭性病原体
曲霉病,形成人类每天吸入的无处不在的空气传播孢子。在免疫能力强的情况下
个体的呼吸道先天免疫系统可以防止组织侵入性菌丝的形成,这是一个关键的因素
免疫检查点。血液系统恶性肿瘤患者、骨髓和肺移植患者
接受者,以及最近在重症监护病房的 COVID-19 患者中,先天的数字或功能缺陷
免疫功能低下导致侵袭性疾病。尽管有现代抗真菌药物,死亡率仍保持在 20-
40% 属于高危人群,强调需要加深对分子和细胞基础的了解
消除免疫力以推进基于免疫的辅助方法。
在第二个资助期,我们利用真菌生物报告仪报告细胞死亡模式来发现
中性粒细胞和单核细胞衍生的树突状细胞在被吞噬的真菌细胞中诱导受调节的细胞死亡。
高等真核生物可以利用低等真核生物中受调节的细胞死亡机制的概念是新颖的
对于烟曲霉来说,取决于宿主 NADPH 氧化酶的活性。 NADPH氧化酶依赖性真菌
杀伤是由两个新颖的、重要的细胞间串扰电路调节的,该电路涉及早期产生
GM-CSF(GM-CSF 回路)和浆细胞样树突状细胞(pDC 回路)。
在下一个项目期间,我们建议更深入地了解 GM-CSF 和 pDC 电路。在
目标 1,我们确定 GM-CSF 的重要细胞来源,并根据初步数据,重点关注肺部
内皮和上皮细胞作为中性粒细胞依赖性真菌杀伤的调节剂。在目标 2 中,我们定义 pDC
电路和候选发射器以及真菌细胞或肺直接或间接激活的测试模型
炎症环境。在目标 3 中,我们定义了 pDC 回路调节中性粒细胞的机制,以及
通过戊糖磷酸测试其在 NAPDH 氧化酶组装、激活和中性粒细胞代谢中的作用
途径及其与 GM-CSF 回路的协同作用以介导灭菌免疫。拟议的研究
具有重要意义和创新性,因为它们整合了肺之间的先天免疫串扰
内皮、上皮和 pDC 区室以及感染的骨髓吞噬细胞形成综合模型
抵抗霉菌病原体的呼吸道免疫力。了解的诱导、调节和参与者
先天免疫串扰解决了一个关键的知识差距,将为免疫增强策略提供信息
弱势患者群体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TOBIAS M HOHL其他文献
TOBIAS M HOHL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TOBIAS M HOHL', 18)}}的其他基金
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
- 批准号:
10415200 - 财政年份:2021
- 资助金额:
$ 67.85万 - 项目类别:
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
- 批准号:
10303678 - 财政年份:2021
- 资助金额:
$ 67.85万 - 项目类别:
Dissection of Macrophage Antifungal Activity against Aspergillus fumigatus
巨噬细胞抗烟曲霉抗真菌活性的剖析
- 批准号:
8584085 - 财政年份:2013
- 资助金额:
$ 67.85万 - 项目类别:
Initiation of the Immune Response to Aspergillus fumigatus
对烟曲霉的免疫反应的启动
- 批准号:
8274640 - 财政年份:2011
- 资助金额:
$ 67.85万 - 项目类别:
Initiation of the Immune Response to Aspergillus fumigatus
对烟曲霉的免疫反应的启动
- 批准号:
8848751 - 财政年份:2011
- 资助金额:
$ 67.85万 - 项目类别:
Initiation of the Immune Response to Aspergillus fumigatus
对烟曲霉的免疫反应的启动
- 批准号:
8735460 - 财政年份:2011
- 资助金额:
$ 67.85万 - 项目类别:
INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUS
对烟曲霉的免疫反应的启动
- 批准号:
10640120 - 财政年份:2011
- 资助金额:
$ 67.85万 - 项目类别:
INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUS
对烟曲霉的免疫反应的启动
- 批准号:
10298001 - 财政年份:2011
- 资助金额:
$ 67.85万 - 项目类别:
Initiation of the Immune Response to Aspergillus fumigatus
对烟曲霉的免疫反应的启动
- 批准号:
8467674 - 财政年份:2011
- 资助金额:
$ 67.85万 - 项目类别:
INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUS
对烟曲霉的免疫反应的启动
- 批准号:
9106836 - 财政年份:2011
- 资助金额:
$ 67.85万 - 项目类别:
相似国自然基金
微波敏感型铁死亡纳米放大器的构建及其增敏肝癌消融-免疫联合治疗的应用与机制研究
- 批准号:82302368
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于光学参量放大器的高灵敏量子干涉仪
- 批准号:62305056
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于太赫兹行波管放大器的高效率多路功率合成技术的研究
- 批准号:62371102
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高增益超宽带CMOS太赫兹放大器关键技术研究
- 批准号:62374026
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
面向超精密电机系统的双降压对称半桥功率放大器噪声机理及抑制策略研究
- 批准号:52307042
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Interferometric and Multiband optical Parametric Amplifiers for Communications (IMPAC)
用于通信的干涉式和多频带光学参量放大器 (IMPAC)
- 批准号:
EP/X031918/1 - 财政年份:2024
- 资助金额:
$ 67.85万 - 项目类别:
Fellowship
SBIR Phase II: Thermally-optimized power amplifiers for next-generation telecommunication and radar
SBIR 第二阶段:用于下一代电信和雷达的热优化功率放大器
- 批准号:
2335504 - 财政年份:2024
- 资助金额:
$ 67.85万 - 项目类别:
Cooperative Agreement
Josephson Parametric Amplifiers using CVD graphene junctions
使用 CVD 石墨烯结的约瑟夫森参量放大器
- 批准号:
EP/Y003152/1 - 财政年份:2024
- 资助金额:
$ 67.85万 - 项目类别:
Research Grant
Emergent Technology for Studying the Structure/Function Relationship of Enzymes Using Electron Paramagnetic Resonance
利用电子顺磁共振研究酶结构/功能关系的新兴技术
- 批准号:
10630488 - 财政年份:2023
- 资助金额:
$ 67.85万 - 项目类别:
Discovery and Applied Research for Technological Innovations to ImproveHuman Health
改善人类健康的技术创新的发现和应用研究
- 批准号:
10841979 - 财政年份:2023
- 资助金额:
$ 67.85万 - 项目类别: